Nonmedical prescribing: where are we now?

被引:107
作者
Cope, Louise C. [1 ]
Abuzour, Aseel S. [2 ]
Tully, Mary P. [2 ]
机构
[1] Manchester Pharm Sch, Drug Usage & Pharm Practice Div, Prescribing & Patient Safety Res Room 132, Manchester M13 9PT, Lancs, England
[2] Univ Manchester, Pharm Sch, Manchester, Lancs, England
关键词
nonmedical prescribing; training programme; history; impact; influences;
D O I
10.1177/2042098616646726
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nonmedical prescribing has been allowed in the United Kingdom (UK) since 1992. Its development over the past 24 years has been marked by changes in legislation, enabling the progression towards independent prescribing for nurses, pharmacists and a range of allied health professionals. Although the UK has led the way regarding the introduction of nonmedical prescribing, it is now seen in a number of other Western-European and Anglophone countries although the models of application vary widely between countries. The programme of study to become a nonmedical prescriber (NMP) within the UK is rigorous, and involves a combination of taught curricula and practice-based learning. Prescribing is a complex skill that is high risk and error prone, with many influencing factors. Literature reports regarding the impact of nonmedical prescribing are sparse, with the majority of prescribing research tending to focus instead on prescribing by doctors. The impact of nonmedical prescribing however is important to evaluate, and can be carried out from several perspectives. This review takes a brief look back at the history of nonmedical prescribing, and compares this with the international situation. It also describes the processes required to qualify as a NMP in the UK, potential influences on nonmedical prescribing and the impact of nonmedical prescribing on patient opinions and outcomes and the opinions of doctors and other healthcare professionals.
引用
收藏
页码:165 / 172
页数:8
相关论文
共 48 条
[1]  
American Pharmacists Association (APA), 2014, TAL 2 COUNTR PATH PH
[2]  
[Anonymous], 2006, DRUG THER B, V44, P33
[3]  
[Anonymous], 2015, NONM PRESCR EC EV
[4]   Prevalence, Nature, Severity and Risk Factors for Prescribing Errors in Hospital Inpatients: Prospective Study in 20 UK Hospitals [J].
Ashcroft, Darren M. ;
Lewis, Penny J. ;
Tully, Mary P. ;
Farragher, Tracey M. ;
Taylor, David ;
Wass, Valerie ;
Williams, Steven D. ;
Dornan, Tim .
DRUG SAFETY, 2015, 38 (09) :833-843
[5]   Pharmacist prescribing within a UK NHS hospital trust: nature and extent of prescribing, and prevalence of errors [J].
Baqir, Wasim ;
Crehan, Olga ;
Murray, Richard ;
Campbell, David ;
Copeland, Richard .
EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2015, 22 (02) :79-82
[6]   Education programmes preparing independent prescribers in Scotland: An evaluation [J].
Boreham, Nick ;
Coull, Alison F. ;
Murray, Ian D. ;
Turner-Halliday, Fiona ;
Watterson, Andrew E. .
NURSE EDUCATION TODAY, 2013, 33 (04) :321-326
[7]   Prescribing privileges among pharmacists in Veterans Affairs medical centers [J].
Clause, S ;
Fudin, J ;
Mergner, A ;
Lutz, JL ;
Kavanaugh, MM ;
Fessler, K ;
Chirumamilla, S .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (12) :1143-1145
[8]   Patients' views of nurse prescribing: effects on care, concordance and medicine taking [J].
Courtenay, M. ;
Carey, N. ;
Stenner, K. ;
Lawton, S. ;
Peters, J. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 164 (02) :396-401
[9]  
Courtenay M., 2007, NURSE PRESCRIBING, V5, P205, DOI [10.12968/npre.2007.5.5.23740, DOI 10.12968/NPRE.2007.5.5.23740]
[10]  
Crown J, 1999, REV PRESCRIBING SUPP